1
|
Sun L, Shen Y, Li M, Wang Q, Li R, Gong S. Comprehensive Assessment of Collagen/Sodium Alginate-Based Sponges as Hemostatic Dressings. Molecules 2024; 29:2999. [PMID: 38998951 PMCID: PMC11243721 DOI: 10.3390/molecules29132999] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2024] [Revised: 06/17/2024] [Accepted: 06/21/2024] [Indexed: 07/14/2024] Open
Abstract
In our search for a biocompatible composite hemostatic dressing, we focused on the design of a novel biomaterial composed of two natural biological components, collagen and sodium alginate (SA), cross-linked using 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide/N-hydroxysuccinimide (EDC/NHS) and oxidized sodium alginate (OSA). We conducted a series of tests to evaluate the physicochemical properties, acute systemic toxicity, skin irritation, intradermal reaction, sensitization, cytotoxicity, and in vivo femoral artery hemorrhage model. The results demonstrated the excellent biocompatibility of the collagen/sodium alginate (C/SA)-based dressings before and after crosslinking. Specifically, the femoral artery hemorrhage model revealed a significantly shortened hemostasis time of 132.5 ± 12.82 s for the EDC/NHS cross-linked dressings compared to the gauze in the blank group (hemostasis time of 251.43 ± 10.69 s). These findings indicated that C/SA-based dressings exhibited both good biocompatibility and a significant hemostatic effect, making them suitable for biomedical applications.
Collapse
Affiliation(s)
- Leilei Sun
- College of Life Science, Yantai University, Yantai 264005, China; (Y.S.); (M.L.); (Q.W.); (R.L.); (S.G.)
| | | | | | | | | | | |
Collapse
|
2
|
Sharma A, Verma C, Singh P, Mukhopadhyay S, Gupta A, Gupta B. Alginate based biomaterials for hemostatic applications: Innovations and developments. Int J Biol Macromol 2024; 264:130771. [PMID: 38467220 DOI: 10.1016/j.ijbiomac.2024.130771] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2023] [Revised: 02/18/2024] [Accepted: 03/08/2024] [Indexed: 03/13/2024]
Abstract
Development of the efficient hemostatic materials is an essential requirement for the management of hemorrhage caused by the emergency situations to avert most of the casualties. Such injuries require the use of external hemostats to facilitate the immediate blood clotting. A variety of commercially available hemostats are present in the market but most of them are associated with limitations such as exothermic reactions, low biocompatibility, and painful removal. Thus, fabrication of an ideal hemostatic composition for rapid blood clot formation, biocompatibility, and antimicrobial nature presents a real challenge to the bioengineers. Benefiting from their tunable fabrication properties, alginate-based hemostats are gaining importance due to their excellent biocompatibility, with >85 % cell viability, high absorption capacity exceeding 500 %, and cost-effectiveness. Furthermore, studies have estimated that wounds treated with sodium alginate exhibited a blood loss of 0.40 ± 0.05 mL, compared to the control group with 1.15 ± 0.13 mL, indicating its inherent hemostatic activity. This serves as a solid foundation for designing future hemostatic materials. Nevertheless, various combinations have been explored to further enhance the hemostatic potential of sodium alginate. In this review, we have discussed the possible role of alginate based composite hemostats incorporated with different hemostatic agents, such as inorganic materials, polymers, biological agents, herbal agents, and synthetic drugs. This article outlines the challenges which need to be addressed before the clinical trials and give an overview of the future research directions.
Collapse
Affiliation(s)
- Ankita Sharma
- Bioengineering Laboratory, Department of Textile and Fibre Engineering, Indian Institute of Technology, New Delhi 110016, India
| | - Chetna Verma
- Bioengineering Laboratory, Department of Textile and Fibre Engineering, Indian Institute of Technology, New Delhi 110016, India
| | - Pratibha Singh
- Bioengineering Laboratory, Department of Textile and Fibre Engineering, Indian Institute of Technology, New Delhi 110016, India
| | - Samrat Mukhopadhyay
- Bioengineering Laboratory, Department of Textile and Fibre Engineering, Indian Institute of Technology, New Delhi 110016, India
| | - Amlan Gupta
- Sikkim Manipal Institute of Medical Sciences, Tadong, Gangtok, Sikkim 737102, India
| | - Bhuvanesh Gupta
- Bioengineering Laboratory, Department of Textile and Fibre Engineering, Indian Institute of Technology, New Delhi 110016, India.
| |
Collapse
|
3
|
Shao H, Wu X, Xiao Y, Yang Y, Ma J, Zhou Y, Chen W, Qin S, Yang J, Wang R, Li H. Recent research advances on polysaccharide-, peptide-, and protein-based hemostatic materials: A review. Int J Biol Macromol 2024; 261:129752. [PMID: 38280705 DOI: 10.1016/j.ijbiomac.2024.129752] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2023] [Revised: 11/05/2023] [Accepted: 01/23/2024] [Indexed: 01/29/2024]
Abstract
Hemorrhage is a potentially life-threatening emergency that can occur at any time or place. Whether traumatic, congenital, surgical, disease-related, or drug-induced, bleeding can lead to severe complications or death. Therefore, the development of efficient hemostatic materials is critical. However, the results and prognosis demonstrated by clinical means of hemostasis do not reach expectations. With the development of technology, novel hemostatic materials have been developed from polysaccharides (chitosan, hyaluronic acid, alginate, cellulose, cyclodextrins, starch, dextran, and carrageenan), peptides (self-assembling peptides), and proteins (silk fibroin, collagen, gelatin, keratin, and thrombin). These new materials exhibit high hemostatic efficacy due to the enhancement or interaction of various hemostatic mechanisms. The main forms include adhesives, sealants, bandages, hemostatic powders, and hemostatic sponges. This article introduces the clotting process and principles of hemostatic methods and reviews the research on polysaccharide-, peptide-, and protein-based hemostatic materials in the last five years. The design ideas and hemostatic principles of polysaccharide-, peptide-, and protein-based hemostatic materials are mainly introduced. Finally, we summarize material designs, advantages, disadvantages, and challenges regarding hemostatic materials.
Collapse
Affiliation(s)
- Hanjie Shao
- Ningbo Medical Center Li Huili Hospital, Health Science Center, Ningbo University, Ningbo 315000, PR China; Zhejiang International Scientific and Technological Cooperative Base of Biomedical Materials and Technology, Institute of Biomedical Engineering, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo 315201, PR China; Ningbo Cixi Institute of Biomedical Engineering, Ningbo 315300, PR China
| | - Xiang Wu
- Ningbo Medical Center Li Huili Hospital, Health Science Center, Ningbo University, Ningbo 315000, PR China; Zhejiang International Scientific and Technological Cooperative Base of Biomedical Materials and Technology, Institute of Biomedical Engineering, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo 315201, PR China; Ningbo Cixi Institute of Biomedical Engineering, Ningbo 315300, PR China
| | - Ying Xiao
- Zhejiang International Scientific and Technological Cooperative Base of Biomedical Materials and Technology, Institute of Biomedical Engineering, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo 315201, PR China; Ningbo Cixi Institute of Biomedical Engineering, Ningbo 315300, PR China
| | - Yanyu Yang
- Zhejiang International Scientific and Technological Cooperative Base of Biomedical Materials and Technology, Institute of Biomedical Engineering, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo 315201, PR China; Ningbo Cixi Institute of Biomedical Engineering, Ningbo 315300, PR China
| | - Jingyun Ma
- Ningbo Institute of Innovation for Combined Medicine and Engineering, The Affiliated Li Huili Hospital, Ningbo University, Ningbo 315100, PR China
| | - Yang Zhou
- Ningbo Institute of Innovation for Combined Medicine and Engineering, The Affiliated Li Huili Hospital, Ningbo University, Ningbo 315100, PR China
| | - Wen Chen
- Ningbo Medical Center Li Huili Hospital, Health Science Center, Ningbo University, Ningbo 315000, PR China
| | - Shaoxia Qin
- Ningbo Medical Center Li Huili Hospital, Health Science Center, Ningbo University, Ningbo 315000, PR China
| | - Jiawei Yang
- Ningbo Medical Center Li Huili Hospital, Health Science Center, Ningbo University, Ningbo 315000, PR China
| | - Rong Wang
- Zhejiang International Scientific and Technological Cooperative Base of Biomedical Materials and Technology, Institute of Biomedical Engineering, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo 315201, PR China; Ningbo Cixi Institute of Biomedical Engineering, Ningbo 315300, PR China.
| | - Hong Li
- Ningbo Medical Center Li Huili Hospital, Health Science Center, Ningbo University, Ningbo 315000, PR China.
| |
Collapse
|
4
|
Mansour A, Acharya AB, Alliot C, Eid N, Badran Z, Kareem Y, Rahman B. Hyaluronic acid in Dentoalveolar regeneration: Biological rationale and clinical applications. J Oral Biol Craniofac Res 2024; 14:230-235. [PMID: 38510340 PMCID: PMC10950752 DOI: 10.1016/j.jobcr.2024.02.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2023] [Revised: 01/17/2024] [Accepted: 02/23/2024] [Indexed: 03/22/2024] Open
Abstract
Background Hyaluronic acid (HA) is found in different locations in the periodontium, including mineralized tissues (i.e., cementum and alveolar bone) and non-mineralized tissues (i.e., gingiva and periodontal ligament). In addition, it seems to play an essential part in regulating the underlying mechanisms involved in tissue inflammatory reactions and wound healing. HA has the potential to regulate periodontal tissue regeneration and treat periodontal disease. Aim The current review of the literature was conducted to assess how HA plays its part in periodontal therapy and examine the contemporary literature's viewpoint on its use in periodontal regeneration. Conclusion HA has a multifunctional character in periodontal regeneration, and healing and appears to provide promising outcomes in different periodontal regenerative applications.
Collapse
Affiliation(s)
- Alaa Mansour
- Periodontology Unit, Department of Preventive and Restorative Dentistry, College of Dentistry, Sharjah University, United Arab Emirates
| | - Anirudh Balakrishna Acharya
- Periodontology Unit, Department of Preventive and Restorative Dentistry, College of Dentistry, Sharjah University, United Arab Emirates
| | - Charles Alliot
- Department of Periodontology, Faculty of Dental Surgery, University of Nantes, Nantes, France
| | - Nael Eid
- Prosthodontics Unit, Department of Preventive and Restorative Dentistry, College of Dentistry, Sharjah University, United Arab Emirates
| | - Zahi Badran
- Periodontology Unit, Department of Preventive and Restorative Dentistry, College of Dentistry, Sharjah University, United Arab Emirates
| | - Yousef Kareem
- College of Dentistry, King Saud University, Riyadh, Saudi Arabia
| | - Betul Rahman
- Periodontology Unit, Department of Preventive and Restorative Dentistry, College of Dentistry, Sharjah University, United Arab Emirates
| |
Collapse
|
5
|
Feng C, Yang L. State of the art, trends, hotspots, and prospects of injection materials for controlling bleeding. Int Wound J 2024; 21:e14644. [PMID: 38272794 PMCID: PMC10789653 DOI: 10.1111/iwj.14644] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/26/2023] [Accepted: 12/18/2023] [Indexed: 01/27/2024] Open
Abstract
Traumatic haemorrhage is a prevalent clinical condition, and effective and timely haemostasis is crucial for the preservation of patients' lives. In recent years, injectable hemostatic materials have gained significant attention due to their excellent hemostatic efficacy, biocompatibility, and biodegradability, making them widely applied in the treatment of incompressible traumatic haemorrhage. Systematic analysis of injectable hemostatic materials is crucial for research in this area. This article provides a comprehensive review of the development and research trends of injectable hemostatic materials over the past 20 years using visualization techniques. Analysis of collaboration and co-citation networks revealed localized research collaboration networks, highlighting the need for enhanced international collaboration in the field of injectable hemostatic materials. Current research focuses primarily on hemostatic materials, hemostatic processes, and hemostatic mechanisms. Injectable hemostatic materials with excellent performance offer promising strategies for wound healing. This review provides a comprehensive and systematic summary of injectable hemostatic materials, offering valuable guidance for the development and clinical application of novel injectable hemostatic materials. Additionally, visualized methodology and mapping analysis are effective data mining methods that provide approaches and strategies for clear knowledge network analysis. These methods facilitate better understanding and interpretation of research dynamics in the field of injectable hemostatic materials, thereby guiding and inspiring future research.
Collapse
Affiliation(s)
- Changsheng Feng
- School of Physics and Electronic InformationYan'an UniversityYan'anChina
| | - Liang Yang
- School of Physics and Electronic InformationYan'an UniversityYan'anChina
| |
Collapse
|
6
|
Xu K, Deng S, Zhu Y, Yang W, Chen W, Huang L, Zhang C, Li M, Ao L, Jiang Y, Wang X, Zhang Q. Platelet Rich Plasma Loaded Multifunctional Hydrogel Accelerates Diabetic Wound Healing via Regulating the Continuously Abnormal Microenvironments. Adv Healthc Mater 2023; 12:e2301370. [PMID: 37437207 DOI: 10.1002/adhm.202301370] [Citation(s) in RCA: 7] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2023] [Revised: 07/01/2023] [Accepted: 07/10/2023] [Indexed: 07/14/2023]
Abstract
Continuous oxidative stress and cellular dysfunction caused by hyperglycemia are distinguishing features of diabetic wounds. It has been a great challenge to develop a smart dressing that can accelerate diabetic wound healing through regulating abnormal microenvironments. In this study, a platelet rich plasma (PRP) loaded multifunctional hydrogel with reactive oxygen species (ROS) and glucose dual-responsive property is reported. It can be conveniently prepared with PRP, dopamine (DA) grafted alginate (Alg-DA), and 6-aminobenzo[c][1,2]oxaborol-1(3H)-ol (ABO) conjugated hyaluronic acid (HA-ABO) through ionic crosslinks, hydrogen-bond interactions, and boronate ester bonds. The hydrogel possesses injectability, moldability, tissue adhesion, self-healing, low hemolysis, and hemostasis performances. Its excellent antioxidant property can create a low oxidative stress microenvironment for other biological events. Under an oxidative stress and/or hyperglycemia state, the hydrogel can degrade at an accelerated rate to release a variety of cytokines derived from activated blood platelets. The result is a series of positive changes that are favorable for diabetic wound healing, including fast anti-inflammation, activated macrophage polarization toward M2 phenotype, promoted migration and proliferation of fibroblasts, as well as expedited angiogenesis. This work provides an efficient strategy for chronic diabetic wound management and offers an alternative for developing a new-type PRP-based bioactive wound dressing.
Collapse
Affiliation(s)
- Kui Xu
- Key Laboratory of Xin'an Medicine, Ministry of Education, Anhui University of Chinese Medicine, Hefei, Anhui, 230038, P. R. China
- Institute of Biomedical Engineering, the Second Clinical Medical College (Shenzhen People's Hospital) of Jinan University, Shenzhen, Guangdong, 518020, P. R. China
- The First Affiliated Hospital, Jinan University, Guangzhou, Guangdong, 510630, P. R. China
| | - Sijie Deng
- Institute of Biomedical Engineering, the Second Clinical Medical College (Shenzhen People's Hospital) of Jinan University, Shenzhen, Guangdong, 518020, P. R. China
| | - Yabin Zhu
- School of Medicine, Ningbo University, Ningbo, Zhejiang, 315211, P. R. China
| | - Wei Yang
- Institute of Biomedical Engineering, the Second Clinical Medical College (Shenzhen People's Hospital) of Jinan University, Shenzhen, Guangdong, 518020, P. R. China
| | - Weizhen Chen
- Center of Clinical Laboratory & the Key Laboratory of Clinical In Vitro Diagnostic Techniques of Zhejiang Province, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310003, P. R. China
| | - Liang Huang
- College of Chemical Engineering, Zhejiang University of Technology, Hangzhou, Zhejiang, 310014, P. R. China
| | - Chi Zhang
- Medical Research Center, Ningbo City First Hospital, Ningbo, Zhejiang, 315010, P. R. China
| | - Ming Li
- Joint Surgery Department, Ningbo No. 6 Hospital, Ningbo, Zhejiang, 315040, P. R. China
| | - Lijiao Ao
- Institute of Biomedical Engineering, the Second Clinical Medical College (Shenzhen People's Hospital) of Jinan University, Shenzhen, Guangdong, 518020, P. R. China
- The First Affiliated Hospital, Jinan University, Guangzhou, Guangdong, 510630, P. R. China
| | - Yibo Jiang
- Institute of Biomedical Engineering, the Second Clinical Medical College (Shenzhen People's Hospital) of Jinan University, Shenzhen, Guangdong, 518020, P. R. China
| | - Xiangyu Wang
- The First Affiliated Hospital, Jinan University, Guangzhou, Guangdong, 510630, P. R. China
| | - Qiqing Zhang
- Institute of Biomedical Engineering, the Second Clinical Medical College (Shenzhen People's Hospital) of Jinan University, Shenzhen, Guangdong, 518020, P. R. China
| |
Collapse
|
7
|
Emami S, Ebrahimi M. Bioactive wound powders as wound healing dressings and drug delivery systems. POWDER TECHNOL 2023. [DOI: 10.1016/j.powtec.2023.118501] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/03/2023]
|
8
|
Gupta R, Mohanty S, Verma D. Current status of hemostatic agents, their mechanism of action, and future directions. J BIOACT COMPAT POL 2023. [DOI: 10.1177/08839115221147935] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/24/2023]
Abstract
The bleeding problem might seem straightforward, but it involves a plethora of complex biochemical pathways and responses. Hemorrhage control remains one of the leading causes of “preventable deaths” worldwide. The past few decades have seen a wide range of biomaterials and their derivatives targeted to serve as hemostatic agents, but none can be deemed as an ideal solution. In this review, we have highlighted the current diversity in hemostatic agents and their modalities. We have enclosed a comprehensive outlook of the proposed solutions and their clinical performance so far. In addition to these, several promising compositions are still in their infancy or developmental phases. The inclusion of novel upcoming nanocomposites has further widened the potencies of existing formulations as well.
Collapse
Affiliation(s)
- Ritvesh Gupta
- Department of Biotechnology and Medical Engineering, National Institute of Technology Rourkela, Odisha, India
| | - Sibanwita Mohanty
- Department of Biotechnology and Medical Engineering, National Institute of Technology Rourkela, Odisha, India
| | - Devendra Verma
- Department of Biotechnology and Medical Engineering, National Institute of Technology Rourkela, Odisha, India
| |
Collapse
|
9
|
de Moraes FM, Philippi JV, Belle F, da Silva FS, Morisso FDP, Volz DR, Ziulkoski AL, Bobinski F, Zepon ΚM. Iota-carrageenan/xyloglucan/serine powders loaded with tranexamic acid for simultaneously hemostatic, antibacterial, and antioxidant performance. BIOMATERIALS ADVANCES 2022; 137:212805. [PMID: 35929232 DOI: 10.1016/j.bioadv.2022.212805] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/27/2022] [Revised: 04/02/2022] [Accepted: 04/12/2022] [Indexed: 11/17/2022]
Abstract
This study sought to prepare powder hemostats based on iota-carrageenan (ιC), xyloglucan (XYL), l-serine (SER), and tranexamic acid (TA). The powder form was chosen because it enables the hemostat to be used in wounds of any shape and depth. The powder hemostats showed irregular shapes and specific surface areas ranging from 34 to 46 m2/g. Increasing TA amount decreases the specific surface area, bulk density, water and blood absorption, and the antibacterial activities of the powder hemostats, but not the water retention ability. Conversely, in vitro biodegradation was positively impacted by increasing the TA content in the powder hemostats. In both the in vitro and in vivo tests, powder hemostats showed reduced bleeding time, significant adhesion of red blood cells, great hemocompatibility, moderate antioxidant activity, and high biocompatibility. These findings shed new light on designing powder hemostats with intrinsic antibacterial and antioxidant activity and excellent hemostatic performance.
Collapse
Affiliation(s)
- Fernanda Mendes de Moraes
- Laboratório de Biomateriais e Biomiméticos, Programa de Pós-Graduação em Ciências Ambientais, Universidade do Sul de Santa Catarina, Tubarão, Brazil
| | - Jovana Volpato Philippi
- Laboratório de Biomateriais e Biomiméticos, Programa de Pós-Graduação em Ciências Ambientais, Universidade do Sul de Santa Catarina, Tubarão, Brazil
| | - Fernanda Belle
- Laboratório de Neurociência Experimental, Programa de Pós-Graduação em Ciências da Saúde, Universidade do Sul de Santa Catarina, Palhoça, Brazil
| | - Francielly Suzaine da Silva
- Laboratório de Neurociência Experimental, Programa de Pós-Graduação em Ciências da Saúde, Universidade do Sul de Santa Catarina, Palhoça, Brazil
| | | | - Débora Rech Volz
- Laboratório de Citotoxicidade, Universidade Feevale, Novo Hamburgo, Brazil
| | | | - Franciane Bobinski
- Laboratório de Neurociência Experimental, Programa de Pós-Graduação em Ciências da Saúde, Universidade do Sul de Santa Catarina, Palhoça, Brazil
| | - Κarine Modolon Zepon
- Laboratório de Biomateriais e Biomiméticos, Programa de Pós-Graduação em Ciências Ambientais, Universidade do Sul de Santa Catarina, Tubarão, Brazil.
| |
Collapse
|
10
|
Sharma S, Anwar MF, Dinda AK, Singhal M, Dua A, Malik A. Polyaspartic acid, 2-acrylamido-2-Methyl propane sulfonic acid and sodium alginate based biocompatible stimuli responsive polymer gel for controlled release of GHK-Cu peptide for wound healing. J Biomater Appl 2022; 37:132-150. [PMID: 35341370 DOI: 10.1177/08853282221076708] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Stimuli responsive polymer based on Polyaspartic acid, 2-Acrylamido-2-methylpropane sulfonic acid and sodium alginate (NaAlg) were synthesized using two cross-linkers Ethylene glycol dimethacrylate (EGDMA) and TMPTA (Trimethylolpropane triacrylate). The polymers were standardized and optimized to obtain a polymer with maximum swelling in distilled water, saline, glucose and solutions of varying pH. The synthesized polymer swelled well in distilled water, glucose solution and acidic- alkaline medium. The biocompatibility of the polymer was evaluated for blood compatibility and protein adsorption. The polymer with maximum swelling property was used for peptide release studies. The polymer was further used to study the peptide encapsulation and release efficiency of the polymeric material which was confirmed by FTIR, Scanning Emission Microscope and EDX. The encapsulation efficiency of the polymer for encapsulating (glycyl-l-histidyl-l-lysine-copper) GHK-Cu was observed to be 55.26% and peptide release of 51.84% was observed for Ethylene glycol dimethacrylate based polymer after 24 h whereas for Trimethylolpropane triacrylate based polymer the encapsulation efficiency was observed to be 49.6% and release was 39.01%. The EGDMA based polymer was further examined under in vivo studies in order to evaluate the efficiency of the synthesized polymer. The in vivo studies include wound closure, histopathological analysis, biochemical and toxicity assay. The material has shown promising results for both in vivo and in vitro studies.
Collapse
Affiliation(s)
- Shilpa Sharma
- Department of Chemistry, 584797Manav Rachna University, Faridabad, India
| | - Mohammad Faiyaz Anwar
- Department of Pathology, 28730All India Institute of Medical Sciences, New Delhi, India
| | - Amit Kumar Dinda
- Department of Plastic Reconstructive and Surgery, 28730All India Institute of Medical Sciences, New Delhi, India
| | - Maneesh Singhal
- Department of Plastic Reconstructive and Surgery, 28730All India Institute of Medical Sciences, New Delhi, India
| | - Amita Dua
- Department of Chemistry, 28782Dyal Singh College, New Delhi, India
| | - Amita Malik
- Department of Chemistry, 28782Dyal Singh College, New Delhi, India
| |
Collapse
|
11
|
Agarwal R, Niezgoda J, Niezgoda J, Madetipati N, Gopalakrishnan S. Advances in Hemostatic Wound Dressings: Clinical Implications and Insight. Adv Skin Wound Care 2022; 35:113-121. [PMID: 34516437 DOI: 10.1097/01.asw.0000790488.72494.57] [Citation(s) in RCA: 8] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
ABSTRACT Hemorrhagic shock is one of the leading causes of prehospital death in the armed forces. In this state, the body begins to shut down because of blood volume depletion. In both civilian and military trauma, a significant number of hemorrhage deaths occur in the first several hours after injury. Researchers all over the globe are working to develop relatively inexpensive and easy-to-transport products to prevent soldiers from going into hemorrhagic shock. For example, many advances have been made during the last several years toward the development of ideal hemostatic dressings. No current hemostatic agents meet all of the requirements, but the ideal dressing would fulfill many important measures: minimizes or stops blood flow within minutes, contains hemostatic agents to enhance blood clotting, is easy to apply, does not need preapplication preparation, has a reasonably long shelf life, is safe to use, prevents bacterial or viral transmission, is stable at extreme temperatures, and is inexpensive. For this literature review, the authors conducted an extensive search of academic scientific databases for relevant keywords and assessed and summarized the results. This review aimed to identify recent advances in hemostatic wound dressings; summarize the currently available dressings and their supporting literature; and discuss the compositions, mechanisms of action, and clinical relevance of each category of dressing. In addition, case studies and suggestions for future research into hemorrhage control with new hemostatic agents are provided.
Collapse
Affiliation(s)
- Roopali Agarwal
- Roopali Agarwal, PhD, MSc, is Faculty, Department of Chemistry, Jamia Hamdard, Hamdard Nagar, New Delhi, India. Jonathan Niezgoda, BS, is Medical Assistant, and Jeffrey Niezgoda, MD, is President and Chief Medical Officer, Advancing the Zenith of Healthcare Wound and Vascular Center, Milwaukee, Wisconsin. Nethaji Madetipati, PharmD, and Sandeep Gopalakrishnan, PhD, are Assistant Professors, College of Nursing, University of Wisconsin Milwaukee. The authors have disclosed no financial relationships related to this article. Submitted March 1, 2021; accepted in revised form May 10, 2021; published online ahead of print September 7, 2021
| | | | | | | | | |
Collapse
|
12
|
Zhu L, Zhang S, Zhang H, Dong L, Cong Y, Sun S, Sun X. Polysaccharides composite materials for rapid hemostasis. J Drug Deliv Sci Technol 2021. [DOI: 10.1016/j.jddst.2021.102890] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
|
13
|
|
14
|
Cirillo G, Pantuso E, Curcio M, Vittorio O, Leggio A, Iemma F, De Filpo G, Nicoletta FP. Alginate Bioconjugate and Graphene Oxide in Multifunctional Hydrogels for Versatile Biomedical Applications. Molecules 2021; 26:1355. [PMID: 33802608 PMCID: PMC7961670 DOI: 10.3390/molecules26051355] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2021] [Revised: 02/27/2021] [Accepted: 02/28/2021] [Indexed: 12/15/2022] Open
Abstract
In this work, we combined electrically-conductive graphene oxide and a sodium alginate-caffeic acid conjugate, acting as a functional element, in an acrylate hydrogel network to obtain multifunctional materials designed to perform multiple tasks in biomedical research. The hybrid material was found to be well tolerated by human fibroblast lung cells (MRC-5) (viability higher than 94%) and able to modify its swelling properties upon application of an external electric field. Release experiments performed using lysozyme as the model drug, showed a pH and electro-responsive behavior, with higher release amounts and rated in physiological vs. acidic pH. Finally, the retainment of the antioxidant properties of caffeic acid upon conjugation and polymerization processes (Trolox equivalent antioxidant capacity values of 1.77 and 1.48, respectively) was used to quench the effect of hydrogen peroxide in a hydrogel-assisted lysozyme crystallization procedure.
Collapse
Affiliation(s)
- Giuseppe Cirillo
- Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende (CS), Italy; (M.C.); (A.L.); (F.I.); (F.P.N.)
| | - Elvira Pantuso
- National Research Council of Italy (CNR)—Institute on Membrane Technology (ITM), 87036 Rende (CS), Italy;
| | - Manuela Curcio
- Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende (CS), Italy; (M.C.); (A.L.); (F.I.); (F.P.N.)
| | - Orazio Vittorio
- Children’s Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW 2031, Australia;
- School of Women’s and Children’s Health, Faculty of Medicine, UNSW Sydney, Sydney, NSW 2052, Australia
- ARC Centre of Excellence for Convergent BioNano Science and Technology, Australian Centre for NanoMedicine, UNSW Sydney, Sydney, NSW 2052, Australia
| | - Antonella Leggio
- Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende (CS), Italy; (M.C.); (A.L.); (F.I.); (F.P.N.)
| | - Francesca Iemma
- Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende (CS), Italy; (M.C.); (A.L.); (F.I.); (F.P.N.)
| | - Giovanni De Filpo
- Department of Chemistry and Chemical Technologies, University of Calabria, 87036 Rende (CS), Italy;
| | - Fiore Pasquale Nicoletta
- Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende (CS), Italy; (M.C.); (A.L.); (F.I.); (F.P.N.)
| |
Collapse
|
15
|
Chen YW, Lu CH, Shen MH, Lin SY, Chen CH, Chuang CK, Ho CC. In vitro evaluation of the hyaluronic acid/alginate composite powder for topical haemostasis and wound healing. Int Wound J 2019; 17:394-404. [PMID: 31845534 DOI: 10.1111/iwj.13285] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2019] [Revised: 12/02/2019] [Accepted: 12/05/2019] [Indexed: 01/14/2023] Open
Abstract
The use of haemostatic agents can provide life-saving treatment for patients who suffer from massive bleeding in both prehospital and intraoperative conditions. However, there are still urgent demands for novel haemostatic materials that exhibit better haemostatic activity, biocompatibility, and biodegradability than existing products. In the present study, we aim to evaluate the feasibility of new wound dressing, RapidClot, for treating uncontrolled haemorrhage through a series of in vitro assessments to determine the swelling ratio, clotting time, enzymatic degradation, haemolytic activity, cytotoxicity, cell proliferation, and migration. The results indicated that the RapidClot revealed better water adsorption capacity and shorter blood clotting time (132.7 seconds) than two commercially available haemostatic agents Celox (378.7 seconds) and WoundSeal (705.3 seconds). Additionally, the RapidClot dressing exhibited a similar level of degradability in the presence of hyaluronidase and lysozyme as that of Celox, whereas negligible degradation of WoundSeal was obtained. Although both Celox and RapidClot revealed a similar level in cell viability (above than 90%) against NIH/3 T3 fibroblasts, improved cell proliferation and migration could be obtained in RapidClot. Taking together, our results demonstrated that RapidClot could possess a great potential for serving as an efficient healing dressing with haemorrhage control ability.
Collapse
Affiliation(s)
- Yi-Wen Chen
- Graduate Institute of Biomedical Sciences, China Medical University, Taichung City, Taiwan.,3D Printing Medical Research Center, China Medical University Hospital, Taichung City, Taiwan
| | - Chia-Hsin Lu
- Research and Development Division, Jing-Te Biomedical Technology Co., Ltd., Taichung City, Taiwan
| | - Meng-Han Shen
- Research and Development Division, Jing-Te Biomedical Technology Co., Ltd., Taichung City, Taiwan
| | - Shih-Yeh Lin
- Research and Development Division, Jing-Te Biomedical Technology Co., Ltd., Taichung City, Taiwan
| | - Chia-Hui Chen
- Research and Development Division, Jing-Te Biomedical Technology Co., Ltd., Taichung City, Taiwan
| | - Ching-Kuang Chuang
- Research and Development Division, Jing-Te Biomedical Technology Co., Ltd., Taichung City, Taiwan
| | - Chia-Che Ho
- Department of Bioinformatics and Medical Engineering, Asia University, Taichung City, Taiwan
| |
Collapse
|